As of Sep 27
| +0.11 / +0.29%|
The 26 analysts offering 12-month price forecasts for Sanofi have a median target of 46.32, with a high estimate of 56.65 and a low estimate of 39.14. The median estimate represents a +21.42% increase from the last price of 38.15.
The current consensus among 27 polled investment analysts is to Hold stock in Sanofi. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.